Search research articles
Contact Us
Filters
Showing results (191-200 of 224) with videos related to
Page
of 23
Sort By:
Blood
|
October 20, 2005
Antimyeloma activity of heat shock protein-90 inhibition
Constantine S Mitsiades, Nicholas S Mitsiades, Ciaran J McMullan, et al.
The Oncologist
|
January 21, 2010
Current multiple myeloma treatment strategies with novel agents: a European perspective
Heinz Ludwig, Meral Beksac, Joan Bladé, et al.
Blood Advances
|
April 23, 2021
Preclinical activity and determinants of response of the GPRC5DxCD3 bispecific antibody talquetamab in multiple myeloma
Christie P M Verkleij, Marloes E C Broekmans, Mark van Duin, et al.
Circulation. Cardiovascular Interventions
|
February 9, 2026
Transcatheter Pulmonary Valve Implantation With the Alterra Adaptive Prestent and SAPIEN 3 Transcatheter Heart Valve: 3-Year Pooled Outcomes of the ALTERRA Trials
Alejandro J Torres, V Vivian Dimas, Shabana Shahanavaz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 6, 2005
International staging system for multiple myeloma
Philip R Greipp, Jesus San Miguel, Brian G M Durie, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 15, 2014
International Myeloma Working Group consensus statement for the management, treatment, and supportive care of patients with myeloma not eligible for standard autologous stem-cell transplantation
Antonio Palumbo, S Vincent Rajkumar, Jesus F San Miguel, et al.
Biorxiv : the Preprint Server for Biology
|
November 28, 2024
Mutagenic impact and evolutionary influence of radiotherapy in hematologic malignancies
Benjamin Diamond, Dhanvantri Chahar, Michael D Jain, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
February 17, 2025
Ensitrelvir for the Treatment of Nonhospitalized Adults with COVID-19: Results from the SCORPIO-HR, Phase 3, Randomized, Double-blind, Placebo-Controlled Trial
Anne F Luetkemeyer, Kara W Chew, Stuart Lacey, et al.
Annals of Hematology
|
May 10, 2021
Real-world comparative effectiveness of triplets containing bortezomib (B), carfilzomib (C), daratumumab (D), or ixazomib (I) in relapsed/refractory multiple myeloma (RRMM) in the US
Faith Davies, Robert Rifkin, Caitlin Costello, et al.
Haematologica
|
February 6, 2014
European Myeloma Network recommendations on the evaluation and treatment of newly diagnosed patients with multiple myeloma
Monika Engelhardt, Evangelos Terpos, Martina Kleber, et al.
Page
of 23
Search research articles
Search
Showing results (191-200 of 224) with videos related to
Sort By:
Page
of 23
Blood
|
October 20, 2005
Antimyeloma activity of heat shock protein-90 inhibition
Constantine S Mitsiades, Nicholas S Mitsiades, Ciaran J McMullan, et al.
The Oncologist
|
January 21, 2010
Current multiple myeloma treatment strategies with novel agents: a European perspective
Heinz Ludwig, Meral Beksac, Joan Bladé, et al.
Blood Advances
|
April 23, 2021
Preclinical activity and determinants of response of the GPRC5DxCD3 bispecific antibody talquetamab in multiple myeloma
Christie P M Verkleij, Marloes E C Broekmans, Mark van Duin, et al.
Circulation. Cardiovascular Interventions
|
February 9, 2026
Transcatheter Pulmonary Valve Implantation With the Alterra Adaptive Prestent and SAPIEN 3 Transcatheter Heart Valve: 3-Year Pooled Outcomes of the ALTERRA Trials
Alejandro J Torres, V Vivian Dimas, Shabana Shahanavaz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 6, 2005
International staging system for multiple myeloma
Philip R Greipp, Jesus San Miguel, Brian G M Durie, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 15, 2014
International Myeloma Working Group consensus statement for the management, treatment, and supportive care of patients with myeloma not eligible for standard autologous stem-cell transplantation
Antonio Palumbo, S Vincent Rajkumar, Jesus F San Miguel, et al.
Biorxiv : the Preprint Server for Biology
|
November 28, 2024
Mutagenic impact and evolutionary influence of radiotherapy in hematologic malignancies
Benjamin Diamond, Dhanvantri Chahar, Michael D Jain, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
February 17, 2025
Ensitrelvir for the Treatment of Nonhospitalized Adults with COVID-19: Results from the SCORPIO-HR, Phase 3, Randomized, Double-blind, Placebo-Controlled Trial
Anne F Luetkemeyer, Kara W Chew, Stuart Lacey, et al.
Annals of Hematology
|
May 10, 2021
Real-world comparative effectiveness of triplets containing bortezomib (B), carfilzomib (C), daratumumab (D), or ixazomib (I) in relapsed/refractory multiple myeloma (RRMM) in the US
Faith Davies, Robert Rifkin, Caitlin Costello, et al.
Haematologica
|
February 6, 2014
European Myeloma Network recommendations on the evaluation and treatment of newly diagnosed patients with multiple myeloma
Monika Engelhardt, Evangelos Terpos, Martina Kleber, et al.
Page
of 23